Page last updated: 2024-10-24

busulfan and Scleroderma, Systemic

busulfan has been researched along with Scleroderma, Systemic in 2 studies

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research Excerpts

ExcerptRelevanceReference
" Prophylaxis for graft-versus-host disease (GVHD) consisted of cyclosporine and methotrexate."3.73Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis. ( Furst, DE; Georges, GE; Henstorf, G; Langston, AA; Lee, J; McSweeney, PA; Nash, RA; Nelson, JL; Shulman, H; Storb, R; Sullivan, KM; Wener, M, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nash, RA1
McSweeney, PA1
Nelson, JL1
Wener, M1
Georges, GE1
Langston, AA1
Shulman, H1
Sullivan, KM1
Lee, J1
Henstorf, G1
Storb, R1
Furst, DE1
Barbata, G1
Giglio, MC1
Granata, G1
Anzalone, A1
Carbone, P1

Other Studies

2 other studies available for busulfan and Scleroderma, Systemic

ArticleYear
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.
    Arthritis and rheumatism, 2006, Volume: 54, Issue:6

    Topics: Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Fibrosis; Graf

2006
Clastogenic and aneuploidizing effects of antiblastic busulphan revealed by kinetochore immunofluorescence in CHO cells.
    Mutation research, 1991, Volume: 263, Issue:4

    Topics: Acetone; Aneuploidy; Busulfan; Cell Line; Centromere; Chromosome Aberrations; Dose-Response Relation

1991